Peptide Blog

All articles and shared info are for educational purposes only.

Latest Peptide Articles

The Synergistic Potential of Fragment 176-191 & CJC-1295 & Ipamorelin Blend in Peptide Based Studies

The Synergistic Potential of Fragment 176-191 & CJC-1295 & Ipamorelin Blend in Peptide Based Studies

Recent investigations into growth hormone secretagogues (GHSs), growth hormone-releasing peptides (GHRPs), and analogs of growth hormone (hGH) have pointed to their potential in modulating endogenous hormone regulation. Individually and in combination, these agents may potentially influence physiological processes such as lipid mobilization, muscle composition, circadian rhythm modulation, and various systemic functions, including gastrointestinal and cardiovascular...
FST-344 Peptide: Transforming Growth Factor-beta (TGF-β) Implications

FST-344 (Follistatin-344) Peptide: Transforming Growth Factor-beta (TGF-β) Implications

Follistatin-344 (FST-344) is an endogenous glycoprotein widely distributed across various tissues. It is classified as an autocrine signaling molecule, meaning that scientists consider it to be synthesized and secreted by cells to bind to their own surface receptors, leading to intracellular modifications. Research suggests that Follistatin exists primarily in two isoforms, FST-317 and FST-344, with...
Copper Peptides and Cell Interaction Research Studies

GHK-Cu and AHK-Cu: Copper Peptides and Cell Interaction Research Studies

Copper peptides are endogenously occurring complexes formed by binding copper ions (Cu2+) to specific amino acid sequences. Among these, glycyl-L-histidyl-L-lysine (GHK-Cu) is the most extensively studied tripeptide. However, other copper-binding peptides such as DAHK-Cu (Aspartyl-Alanyl-Histidyl-Lysine) and AHK-Cu (Alanine-Histidine-Lysine) have also been identified. These peptides have reportedly been studied for their potential roles in gene expression,...
Proxofim Peptide & Cellular Apoptosis

Proxofim Peptide and Cellular Apoptosis: A Research Summary

FOXO4-D-Retro-Inverso (FOXO4-DRI), also called Proxofim peptide, is a synthetic variant of the endogenous FOXO4 protein. This synthetic variant is developed with D-amino acids in place of the endogenously occurring L-amino acids. This modification was made in the hope of supporting stability by reducing susceptibility to proteolytic degradation, thereby increasing the potential to extend a cellular...
Bremelanotide Peptide: HSDD Related-Research

Bremelanotide Peptide and HSDD Related-Research

Bremelanotide, also known as PT-141, is a synthetic cyclic heptapeptide derived from Melanotan II (MT-II), a synthetic analog of the melanocortin hormone α-melanocyte-stimulating hormone (α-MSH). It was initially investigated for its potential role in addressing hypoactive sexual desire disorder (HSDD) in female research models, as evaluated in Phase IIb clinical trials by qualified researchers. Research...
Pralmorelin Peptide & Growth Hormone Secretegogue Receptors

Pralmorelin Peptide and Growth Hormone Secretegogue Receptors (GHS-Rs)

Pralmorelin, also referred to as Growth Hormone Releasing Peptide-2 (GHRP-2), is a synthetic pentapeptide classified as a growth hormone secretagogue. Structurally analogous to met-enkephalin, it appears to lack opioid activity and instead interacts with the ghrelin/growth hormone secretagogue receptors (GHS-Rs) to stimulate growth hormone (GH) release. Initially developed as a diagnostic agent for assessing GH...
Insights into the Tesamorelin

Insights into the Tesamorelin, Ipamorelin, and CJC-1295 Peptide Blend

The Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin peptide blend represents a combination of synthetic peptides, each with distinct properties that researchers have hypothesized may hold mechanisms for stimulating growth hormone (GH) synthesis and secretion. Although structurally and functionally unique, these peptides appear to share a common focus on modulating the endocrine system's GH...
Liraglutide Peptide Potential in Obesity and Diabetes Research

Liraglutide Peptide: Potential in Obesity and Diabetes Research

Liraglutide is a synthetic analog of the glucagon-like peptide-1 (GLP-1), an endogenous incretin hormone known for its potential role in regulating glucose metabolism and appetite. Classified as a lipopeptide, Liraglutide peptide is suggested to be structurally similar to GLP-1, sharing 97% homology with its natural counterpart and containing 31 amino acids, including an arginine residue...
Modified GRF 1-29 & Ipamorelin Blend Studies in Growth Hormone Secretion and Metabolic Regulation

Modified GRF 1-29 & Ipamorelin Blend: Studies in Growth Hormone Secretion and Metabolic Regulation

The Modified GRF 1-29 and Ipamorelin blend represents a significant advancement in peptide-based research, particularly for its potential to influence growth hormone secretion and metabolic processes. This synergistic combination pairs two complementary peptides with distinct but interconnected roles, which is considered pivotal in this branch of scientific research. Modified GRF 1-29, a stabilized analog of...
1 2 3 19